Durbin, Anna P <br/><br/>
A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial.  [electronic resource] 

 -  PLoS neglected tropical diseases  Aug 2011 
 - e1267 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1935-2735 
<br/><br/><label>Standard No.: </label>10.1371/journal.pntd.0001267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Viral--blood<br/>Cohort Studies<br/>Dengue--blood<br/>Dengue Vaccines--administration & dosage<br/>Dengue Virus--immunology<br/>Female<br/>Humans<br/>Immunization Schedule<br/>Immunization, Secondary<br/>Male<br/>Neutralization Tests<br/>Placebos<br/>Vaccines, Attenuated--administration & dosage<br/>Viremia--immunology